These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9272332)

  • 21. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines.
    Geier DA; Geier MR
    Brain Dev; 2004 Aug; 26(5):296-300. PubMed ID: 15165669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of whole-cell pertussis vaccines.
    Plotkin SA
    Dev Biol Stand; 1997; 89():171-4. PubMed ID: 9272348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public health perspectives on the rising incidence of pertussis.
    Judelsohn RG; Koslap-Petraco MB
    Public Health Nurs; 2007; 24(5):421-8. PubMed ID: 17714226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absolute efficacy of acellular pertussis vaccines in household settings.
    Storsaeter J; Gustafsson L
    Dev Biol Stand; 1997; 89():153-9. PubMed ID: 9272345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
    Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
    Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pertussis vaccines.
    Edwards KM; Karzon DT
    Pediatr Clin North Am; 1990 Jun; 37(3):549-66. PubMed ID: 2190139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Pichichero ME; Decker MD
    Biologicals; 2005 Mar; 33(1):59. PubMed ID: 15713557
    [No Abstract]   [Full Text] [Related]  

  • 31. Pertussis vaccine research.
    Manclark CR
    Bull World Health Organ; 1981; 59(1):9-15. PubMed ID: 7020972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction to the International Symposium on Pertussis Evaluation and Research on Acellular Pertussis Vaccines.
    Oya A
    Dev Biol Stand; 1991; 73():3-4. PubMed ID: 1778323
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunization update: pertussis, meningoccocus, and human papillomavirus.
    Middleman AB
    Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public health application of acellular pertussis vaccines.
    Hadler SC; Orenstein WA
    Dev Biol Stand; 1997; 89():355-61. PubMed ID: 9272371
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of serological results in the NIAID Multicenter Acellular Pertussis Trial with recent efficacy trials.
    Edwards KM; Decker MD
    Dev Biol Stand; 1997; 89():265-73. PubMed ID: 9272359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and acellular pertussis vaccines in adults.
    Keitel WA
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S118-23. PubMed ID: 10447029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the possibility of serious adverse events from the whole cell pertussis vaccine: were metabolically vulnerable children at risk?
    Wilson K; Potter B; Manuel D; Keelan J; Chakraborty P
    Med Hypotheses; 2010 Jan; 74(1):150-4. PubMed ID: 19660877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.